PubMed Central (PMC) Search Page
Table representation of search results timeline featuring number of search results per year.
| Year | Number of Results |
|---|---|
| 1996 | 1 |
| 1998 | 1 |
| 2001 | 2 |
| 2002 | 2 |
| 2003 | 1 |
| 2004 | 8 |
| 2005 | 18 |
| 2006 | 36 |
| 2007 | 65 |
| 2008 | 94 |
| 2009 | 118 |
| 2010 | 291 |
| 2011 | 316 |
| 2012 | 308 |
| 2013 | 352 |
| 2014 | 316 |
| 2015 | 398 |
| 2016 | 288 |
| 2017 | 292 |
| 2018 | 317 |
| 2019 | 286 |
| 2020 | 324 |
| 2021 | 326 |
| 2022 | 272 |
| 2023 | 251 |
| 2024 | 291 |
| 2025 | 240 |
| 2026 | 196 |
-
Publication date
-
-
Publication stage
These filters represent the three primary types of content included in the PMC archive: 1) content published in a scholarly journal 2) peer-reviewed author manuscripts accepted for publication in a journal and 3) preprint versions of articles collected through the NIH Preprint Pilot, made public prior to peer review
-
-
Collections
The PMC Open Access Subset includes journal articles and preprints that are made available under license terms that allow reuse. Historical back issues refers to digitized content from print journals made available in PMC through the Biomedical Journal Digitization Projects.
-
"Neuropsychopharmacology"[Journal]
The embargo is the time during which the publisher retains exclusive rights to distribute articles. Those articles are made freely available on the PMC website after the embargo period has ended. Citations for articles under an embargo period will still display in the PMC results list by default. Choose “Exclude” to prevent embargoed articles from displaying in your results.
-
Intermittent and extended cocaine access attenuate cocaine-vs-food choice in male and female rats.
- Marsh SA, Negus SS, Banks ML.
- Neuropsychopharmacology. Author manuscript. 2026 Sep 8:10.1038/s41386-026-02542-8. doi: 10.1038/s41386-026-02542-8. Online ahead of print.
- PMCID: PMC13670111
Marsh SA, et al.Neuropsychopharmacology. Author manuscript. 2026.PMCID: PMC13670111 -
Modulation of GABA and glutamate by ketamine in depression: A systematic review and meta-analysis of magnetic resonance spectroscopy studies.
- Singh B, Ali HM, Miola A, Nunez NA, Fogaça MV, Jelen LA, Prokop LJ, Sanacora G, Zarate CA Jr, Frye MA, Port JD.
- Neuropsychopharmacology. Author manuscript. 2026 Sep 21:10.1038/s41386-026-02562-4. doi: 10.1038/s41386-026-02562-4. Online ahead of print.
- PMCID: PMC13663534
Singh B, et al.Neuropsychopharmacology. Author manuscript. 2026.PMCID: PMC13663534 -
Auditory event-related potentials and psychosis dimensions.
- Trayvick J, Perlman G, Jonas KG, Donaldson KR, Foti D, Bromet EJ, Kotov R, Nelson BD.
- Neuropsychopharmacology. Author manuscript. 2026 Jul 4;51(11):2102-2110. doi: 10.1038/s41386-026-02487-y.
- PMCID: PMC13598103
Trayvick J, et al.Neuropsychopharmacology. Author manuscript. 2026.PMCID: PMC13598103 -
Evenamide reverses schizophrenia-related dysfunction in a neurodevelopmental animal model.
- Uliana DL, Walsh RA, Fabris D, Grace AA.
- Neuropsychopharmacology. 2025 Aug 5;50(11):1631-1642. doi: 10.1038/s41386-025-02188-y.
- PMCID: PMC12436616
Uliana DL, et al.Neuropsychopharmacology. 2025.PMCID: PMC12436616 -
Safety and tolerability of multiple sublingual microdoses of 5-MeO-DMT in adults with moderate symptoms of depression and/or anxiety: a randomized, double-blind, placebo-controlled study.
- Bistue Millón MB, Noguera L, Bruno D, Vita L, Zanino M, Kassuha DE, Ortiz JE, Feresin GE, Díaz-Dellavalle P, Orosco L, Garcés MA, Diez P, Albarracín SG, Bruno MA.
- Neuropsychopharmacology. 2025 Jul 15;50(11):1715-1723. doi: 10.1038/s41386-025-02167-3.
- PMCID: PMC12436647
Bistue Millón MB, et al.Neuropsychopharmacology. 2025.PMCID: PMC12436647 -
Targeting depression circuitry with H1 coil Transcranial Magnetic Stimulation: a retrospective circuit mapping study.
- Baldi S, Chiulli N, Palm S, Frandsen S, Pell GS, Zibman S, Rodriguez-Ponde J, Brown JC, Siddiqi SH.
- Neuropsychopharmacology. 2025 Jun 30;50(11):1674-1682. doi: 10.1038/s41386-025-02157-5.
- PMCID: PMC12436620
Baldi S, et al.Neuropsychopharmacology. 2025.PMCID: PMC12436620 -
Using causal network mapping to clarify pre-clinical brain stimulation results.
- Webler RD, King D, Balderston NL, Siddiqi SH.
- Neuropsychopharmacology. 2025 Jun 25;50(11):1752-1753. doi: 10.1038/s41386-025-02153-9.
- PMCID: PMC12436646
Webler RD, et al.Neuropsychopharmacology. 2025.PMCID: PMC12436646 -
Unraveling time-dependent genetic components underlying alcohol response.
- Hikino K, Otsuka I, Oshima S, Hishimoto A, Ozaki K, Liu X, Ishikawa Y, Mushiroda T, Matsushita S, Terao C.
- Neuropsychopharmacology. 2025 Jun 21;50(11):1665-1673. doi: 10.1038/s41386-025-02147-7.
- PMCID: PMC12436600
Hikino K, et al.Neuropsychopharmacology. 2025.PMCID: PMC12436600 -
Prefrontal corticotropin-releasing factor promotes resilience to social stress.
- Wang YT, Li Y, Li MY, Zhang YM, Wang Y, Xu QQ, Liu RY, Qin XY, Shan QH, Wang Y, Zhou JN, Chen P.
- Neuropsychopharmacology. 2025 Jun 10;50(11):1620-1630. doi: 10.1038/s41386-025-02148-6.
- PMCID: PMC12436653
Wang YT, et al.Neuropsychopharmacology. 2025.PMCID: PMC12436653 -
DLPFC: The Decade circLe CCNP Family Cohort.
- Zhang Z, Yang N.
- Neuropsychopharmacology. 2025 May 21;50(11):1617-1619. doi: 10.1038/s41386-025-02131-1.
- PMCID: PMC12436588
Zhang Z, et al.Neuropsychopharmacology. 2025.PMCID: PMC12436588